Arthur Karmen, M.D. established the first global standard for measuring blood transaminases (AST/ALT) to diagnose myocardial infarctions (heart attacks) and liver disease.
In 1954, Dr. Karmen developed the definitive enzymatic method for detecting transaminase activity in blood serum. This discovery allowed physicians to definitively confirm tissue damage following a heart attack or during active liver disease.




















